๏ธ

Mike is a corporate transactional lawyer focused on finding practical, actionable solutions for a wide range of clients, including public companies (often small- and mid-cap companies listed on NASDAQ), private equity firms and their portfolio companies, large family-owned businesses, development-stage enterprises, and entrepreneurs. Mike is a trusted advisor and often serves as outside general counsel to his clients.

As a Partner in Wiggin and Danaโ€™s Corporate Department, he believes legal issues can always be solved in a business-minded way. That is his goal as he assists clients in domestic and cross-border mergers, acquisitions, and divestitures; public offerings and private placements of equity, debt, and hybrid securities, including extensive experience in PIPE transactions; public company compliance with federal and state securities laws and reporting requirements; corporate governance; exchange and tender offers; and general business counseling (including assisting in the organization, development, and financing of growth-stage companies).

For example, Mike has recently advised clients in strategic acquisitions and divestitures; underwritten public offerings; secured-debt-financing transactions; acquisitions by major media companies; and financial restructurings.

Mikeโ€™s practice spans a broad range of companies and industries, including biotechnology and medical device, paper products and coatings, software and technology, automotive parts, specialty manufacturing and distribution companies, service companies, and investment funds.

Mike earned his law degree from Duke University School of Law and graduated magna cum laude from the University of Pennsylvania.

Education

  • Duke University School of Law (J.D., 1989)
  • University of Pennsylvania (B.A., 1986)
    • magna cum laude

Bar Admissions

Awards and Recognitions

The Legal 500 (2022)

Mergers and Acquisitions Case Study: A Timely Exit Transaction

Publications

Load More

Events

When: December 17, 2013

People: Michael Grundei

When: November 6, 2012

People: Michael Grundei

When: May 9, 2011

People: Michael Grundei

When: May 9, 2011

People: Michael Grundei

When: July 17, 2007

People: Michael Grundei

When: October 5, 2005

People: Michael Grundei

Experience

  • Represented numerous publicly traded companies in connection with their Securities Exchange Act compliance and other securities matters, including Hudson Technologies, Inc. (Nasdaq), Misonix, Inc. (Nasdaq), CAS Medical Systems, Inc. (Nasdaq), Biodel Inc. (Nasdaq), TRC Companies, Inc. (NYSE) and ATMI, Inc. (Nasdaq)
  • Represented CAS Medical Systems, Inc. (Nasdaq) in all aspects of its sale, via cash out merger, to a subsidiary of Edwards Lifesciences Corporation (NYSE)
  • Represented Hudson Technologies, Inc. (Nasdaq) in connection with the $220 million acquisition of Airgas Refrigerants, Inc. and related term and revolving debt financings
  • Represented Hudson Technologies, Inc. (Nasdaq) in connection with a $50 million secondary public offering of common stock underwritten by William Blair & Company and Craig-Hallum Capital Group
  • Represented Biodel Inc. (Nasdaq) in connection with a $35 million secondary public offering of common stock underwritten by William Blair & Company and Ladenburg Thalmann
  • Represented The Hour Publishing Company in connection with the sale of its media assets to Hearst
  • Represented CAS Medical Systems, Inc. (Nasdaq) in connection with the sale of its neonatal intensive care disposables product line to Trinity Medical Devices Inc.
  • Represented R Tape Corp. in connection with its sale to Nekoosa Coated Products, a portfolio company of Wingate Partners
  • Represented UIL Holdings Corporation (NYSE) in connection with a $500 million public offering of common stock underwritten by Morgan Stanley, JP Morgan and BofA Merrill Lynch
  • Represented Latex Foam International Holdings, Inc. in connection with the corporate aspects of its financial restructuring and emergence from Chapter 11 bankruptcy

Firm Highlights